Editors


Peter Clausi

About Peter Clausi

Mr. Clausi is an experienced investment banker, executive, director and shareholder activist. A graduate of Osgoode Hall Law School called to Ontario's bar in 1990, Mr. Clausi has extensive experience in finance, shareholder rights, proxy battles and corporate growth. Mr. Clausi has been a guest lecturer at three Ontario MBA programs, and was an instructor at the Law Society of Upper Canada's bar admission course for over 10 years. He makes frequent appearances as a shareholder rights and board governance advocate. Among other roles he is the CEO of CBLT Inc., and an independent director and audit committee member of Camrova Resources.

20 InvestorIntel Articles By Peter Clausi

image_pdfimage_print

Goodbye, SEDAR. Hello, SEDAR+

In theory, Sedar (System for Electronic Document Analysis and Retrieval) was intended to be a filing system developed for the […]


Looking Beyond USD for Gold

Note from Peter Clausi: On June 24, 2019 I originally published this piece. Today, it is arguably even more relevant; […]


Global expert Dev Randhawa on the uranium market and Fission 3.0’s expanding portfolio in the Athabasca Basin

Peter Clausi starts this InvestorIntel interview with ‘global expert’ Dev Randhawa, Chairman and CEO of Fission 3.0 Corp. (TSXV: FUU […]


Geoff Atkins discusses exceeding expectations in Vital Metals’ output of rare earths with Peter Clausi

In a recent InvestorIntel interview, Peter Clausi spoke with Geoff Atkins, Managing Director of Vital Metals Limited (ASX: VML) about Vital […]


Black Opportunity Fund’s Colin Lynch on building a $1.5 billion fund

In a recent InvestorIntel interview, Peter Clausi spoke with Colin Lynch, a member of the Board and a Founding Member […]


Darren Hazelwood on Panther Metals’ prospective gold projects in Ontario’s Schreiber-Hemlo Greenstone Belt

In a recent InvestorIntel interview, Peter Clausi spoke with Darren Hazelwood, CEO of Panther Metals PLC (LSE: PALM) about Panther’s […]


Dev Randhawa on Fission 3.0’s private placement and the uranium market

In a recent InvestorIntel interview, Peter Clausi spoke with Dev Randhawa, Chairman and CEO of Fission 3.0 Corp. (TSXV: FUU | OTCQB: […]


Fission 3.0’s Dev Randhawa on the Uranium Boomlet

In a recent InvestorIntel interview, Peter Clausi spoke with Dev Randhawa, Chairman and CEO of Fission 3.0 Corp. (TSXV: FUU […]


Thomas Smeenk with an update on the FDA Phase II clinical trial program of the Hemostemix blood-derived, stem cell therapeutics product (ACP-01)

In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV: HEM | […]


Dev Randhawa on Fission 3.0 and why ESG Investors are looking at Uranium

In a recent InvestorIntel interview, Peter Clausi speaks with Dev Randhawa, Chairman and CEO of Fission 3.0 Corp. (TSXV: FUU […]